Long Circulation of PEG-TRAIL Improves Anti-Hepatic Fibrosis Effect of TRAIL Via Targeting Activated Hepatic Stellate Cells

• Bingyun Lu,
• Lijun Peng,
• Shenggen Luo,
• Jing’e Zhou,
• Nan Xu,
• Chunxiu Dong,
• Zhiqiang Yan,
• Huiyi Li,
• Qinghua Li

Affiliations

Bingyun Lu

Department of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai, China

Lijun Peng

Department of Gastroenterology, Linyi People’s Hospital, Linyi, Shandong, China

Shenggen Luo

Institute of Biomedical Engineering and Technology, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China

Jing’e Zhou

Institute of Biomedical Engineering and Technology, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China

Nan Xu

Institute of Biomedical Engineering and Technology, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China

Chunxiu Dong

Department of Hepatology and Pancreatology, Shanghai East Hospital, Tongji University, Shanghai, China

Zhiqiang Yan

Institute of Biomedical Engineering and Technology, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China

Huiyi Li

Department of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai, China

Qinghua Li

Department of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai, China